Wordt geladen...
Response to cholinesterase inhibitors affects lifespan in Alzheimer’s disease
BACKGROUND: A varying response to cholinesterase inhibitor (ChEI) treatment has been reported among patients with Alzheimer’s disease (AD). Whether the individual-specific response, specific ChEI agent or dose affects mortality is unclear. We aimed to examine the relationship between the 6-month res...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4172846/ https://ncbi.nlm.nih.gov/pubmed/25213579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-014-0173-4 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|